nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.2	0.354	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Etoposide—sarcoma	0.157	0.278	CiPCiCtD
Topotecan—peripheral nervous system neoplasm—sarcoma	0.135	0.506	CtDrD
Topotecan—lung cancer—sarcoma	0.131	0.494	CtDrD
Topotecan—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.108	0.191	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—sarcoma	0.0999	0.177	CiPCiCtD
Topotecan—ABCG2—Dactinomycin—sarcoma	0.0222	0.176	CbGbCtD
Topotecan—ABCG2—Mitoxantrone—sarcoma	0.0198	0.157	CbGbCtD
Topotecan—ABCG2—Vincristine—sarcoma	0.0136	0.108	CbGbCtD
Topotecan—ABCG2—Etoposide—sarcoma	0.0125	0.0992	CbGbCtD
Topotecan—CYP3A4—Thiotepa—sarcoma	0.00996	0.079	CbGbCtD
Topotecan—ABCG2—Doxorubicin—sarcoma	0.00853	0.0677	CbGbCtD
Topotecan—ABCB1—Dactinomycin—sarcoma	0.00799	0.0634	CbGbCtD
Topotecan—ABCB1—Mitoxantrone—sarcoma	0.00715	0.0567	CbGbCtD
Topotecan—ABCB1—Vincristine—sarcoma	0.00492	0.039	CbGbCtD
Topotecan—ABCB1—Etoposide—sarcoma	0.00451	0.0358	CbGbCtD
Topotecan—CYP3A4—Mitoxantrone—sarcoma	0.00428	0.034	CbGbCtD
Topotecan—ABCB1—Doxorubicin—sarcoma	0.00307	0.0244	CbGbCtD
Topotecan—CYP3A4—Vincristine—sarcoma	0.00295	0.0234	CbGbCtD
Topotecan—CYP3A4—Etoposide—sarcoma	0.0027	0.0214	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—sarcoma	0.00184	0.0146	CbGbCtD
Topotecan—TOP1—mammary gland—sarcoma	0.000518	0.107	CbGeAlD
Topotecan—TOP1—myometrium—sarcoma	0.000367	0.0759	CbGeAlD
Topotecan—TOP1—seminal vesicle—sarcoma	0.000332	0.0685	CbGeAlD
Topotecan—TOP1MT—testis—sarcoma	0.000328	0.0677	CbGeAlD
Topotecan—TOP1MT—liver—sarcoma	0.00031	0.064	CbGeAlD
Topotecan—TOP1—smooth muscle tissue—sarcoma	0.000278	0.0574	CbGeAlD
Topotecan—TOP1—cardiac atrium—sarcoma	0.00024	0.0495	CbGeAlD
Topotecan—TOP1—uterus—sarcoma	0.000238	0.0492	CbGeAlD
Topotecan—TOP1MT—lymph node—sarcoma	0.000238	0.0491	CbGeAlD
Topotecan—TOP1—tendon—sarcoma	0.000209	0.0431	CbGeAlD
Topotecan—TOP1—bone marrow—sarcoma	0.000202	0.0418	CbGeAlD
Topotecan—TOP1—testis—sarcoma	0.000173	0.0357	CbGeAlD
Topotecan—TOP1—liver—sarcoma	0.000163	0.0337	CbGeAlD
Topotecan—ABCG2—myometrium—sarcoma	0.00013	0.0269	CbGeAlD
Topotecan—TOP1—lymph node—sarcoma	0.000125	0.0259	CbGeAlD
Topotecan—ABCG2—seminal vesicle—sarcoma	0.000118	0.0243	CbGeAlD
Topotecan—ABCG2—uterus—sarcoma	8.46e-05	0.0175	CbGeAlD
Topotecan—CYP3A4—hematopoietic system—sarcoma	7.8e-05	0.0161	CbGeAlD
Topotecan—ABCG2—bone marrow—sarcoma	7.18e-05	0.0148	CbGeAlD
Topotecan—ABCB1—myometrium—sarcoma	6.43e-05	0.0133	CbGeAlD
Topotecan—Back pain—Etoposide—sarcoma	6.26e-05	0.00164	CcSEcCtD
Topotecan—Pain—Dactinomycin—sarcoma	6.24e-05	0.00163	CcSEcCtD
Topotecan—Anaphylactoid reaction—Epirubicin—sarcoma	6.23e-05	0.00163	CcSEcCtD
Topotecan—Muscle spasms—Etoposide—sarcoma	6.22e-05	0.00163	CcSEcCtD
Topotecan—Thrombocytopenia—Mitoxantrone—sarcoma	6.22e-05	0.00163	CcSEcCtD
Topotecan—Anorexia—Vincristine—sarcoma	6.22e-05	0.00162	CcSEcCtD
Topotecan—ABCB1—embryo—sarcoma	6.18e-05	0.0128	CbGeAlD
Topotecan—Skin disorder—Mitoxantrone—sarcoma	6.17e-05	0.00161	CcSEcCtD
Topotecan—Lethargy—Epirubicin—sarcoma	6.15e-05	0.00161	CcSEcCtD
Topotecan—Hyperhidrosis—Mitoxantrone—sarcoma	6.14e-05	0.0016	CcSEcCtD
Topotecan—ABCG2—testis—sarcoma	6.13e-05	0.0127	CbGeAlD
Topotecan—Feeling abnormal—Thiotepa—sarcoma	6.06e-05	0.00158	CcSEcCtD
Topotecan—Anorexia—Mitoxantrone—sarcoma	6.05e-05	0.00158	CcSEcCtD
Topotecan—Feeling abnormal—Dactinomycin—sarcoma	6.02e-05	0.00157	CcSEcCtD
Topotecan—Gastrointestinal pain—Thiotepa—sarcoma	6.01e-05	0.00157	CcSEcCtD
Topotecan—Ill-defined disorder—Etoposide—sarcoma	6.01e-05	0.00157	CcSEcCtD
Topotecan—Anaemia—Etoposide—sarcoma	5.98e-05	0.00156	CcSEcCtD
Topotecan—Gastrointestinal pain—Dactinomycin—sarcoma	5.97e-05	0.00156	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Vincristine—sarcoma	5.94e-05	0.00155	CcSEcCtD
Topotecan—Paraesthesia—Vincristine—sarcoma	5.86e-05	0.00153	CcSEcCtD
Topotecan—Urticaria—Thiotepa—sarcoma	5.84e-05	0.00153	CcSEcCtD
Topotecan—Malaise—Etoposide—sarcoma	5.84e-05	0.00153	CcSEcCtD
Topotecan—Dermatitis bullous—Doxorubicin—sarcoma	5.83e-05	0.00152	CcSEcCtD
Topotecan—Body temperature increased—Thiotepa—sarcoma	5.81e-05	0.00152	CcSEcCtD
Topotecan—Abdominal pain—Thiotepa—sarcoma	5.81e-05	0.00152	CcSEcCtD
Topotecan—ABCB1—seminal vesicle—sarcoma	5.81e-05	0.012	CbGeAlD
Topotecan—ABCG2—liver—sarcoma	5.8e-05	0.012	CbGeAlD
Topotecan—Leukopenia—Etoposide—sarcoma	5.79e-05	0.00151	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Mitoxantrone—sarcoma	5.79e-05	0.00151	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—sarcoma	5.77e-05	0.00151	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—sarcoma	5.77e-05	0.00151	CcSEcCtD
Topotecan—Anaphylactoid reaction—Doxorubicin—sarcoma	5.76e-05	0.00151	CcSEcCtD
Topotecan—Cardiac arrest—Epirubicin—sarcoma	5.73e-05	0.0015	CcSEcCtD
Topotecan—Paraesthesia—Mitoxantrone—sarcoma	5.7e-05	0.00149	CcSEcCtD
Topotecan—Lethargy—Doxorubicin—sarcoma	5.69e-05	0.00149	CcSEcCtD
Topotecan—Decreased appetite—Vincristine—sarcoma	5.67e-05	0.00148	CcSEcCtD
Topotecan—Dyspnoea—Mitoxantrone—sarcoma	5.66e-05	0.00148	CcSEcCtD
Topotecan—Cough—Etoposide—sarcoma	5.65e-05	0.00148	CcSEcCtD
Topotecan—Gastrointestinal disorder—Vincristine—sarcoma	5.63e-05	0.00147	CcSEcCtD
Topotecan—Fatigue—Vincristine—sarcoma	5.62e-05	0.00147	CcSEcCtD
Topotecan—Dyspepsia—Mitoxantrone—sarcoma	5.59e-05	0.00146	CcSEcCtD
Topotecan—Constipation—Vincristine—sarcoma	5.58e-05	0.00146	CcSEcCtD
Topotecan—Pain—Vincristine—sarcoma	5.58e-05	0.00146	CcSEcCtD
Topotecan—Decreased appetite—Mitoxantrone—sarcoma	5.52e-05	0.00144	CcSEcCtD
Topotecan—ABCB1—hematopoietic system—sarcoma	5.52e-05	0.0114	CbGeAlD
Topotecan—Chest pain—Etoposide—sarcoma	5.51e-05	0.00144	CcSEcCtD
Topotecan—Fatigue—Mitoxantrone—sarcoma	5.48e-05	0.00143	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	5.47e-05	0.00143	CcSEcCtD
Topotecan—Discomfort—Etoposide—sarcoma	5.45e-05	0.00142	CcSEcCtD
Topotecan—Constipation—Mitoxantrone—sarcoma	5.43e-05	0.00142	CcSEcCtD
Topotecan—Pain—Mitoxantrone—sarcoma	5.43e-05	0.00142	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Epirubicin—sarcoma	5.43e-05	0.00142	CcSEcCtD
Topotecan—Hypersensitivity—Thiotepa—sarcoma	5.42e-05	0.00142	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—sarcoma	5.38e-05	0.00141	CcSEcCtD
Topotecan—Gastrointestinal pain—Vincristine—sarcoma	5.33e-05	0.00139	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Epirubicin—sarcoma	5.31e-05	0.00139	CcSEcCtD
Topotecan—Cardiac arrest—Doxorubicin—sarcoma	5.3e-05	0.00139	CcSEcCtD
Topotecan—Anaphylactic shock—Etoposide—sarcoma	5.28e-05	0.00138	CcSEcCtD
Topotecan—Asthenia—Thiotepa—sarcoma	5.28e-05	0.00138	CcSEcCtD
Topotecan—Infection—Etoposide—sarcoma	5.25e-05	0.00137	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—sarcoma	5.24e-05	0.00137	CcSEcCtD
Topotecan—Feeling abnormal—Mitoxantrone—sarcoma	5.23e-05	0.00137	CcSEcCtD
Topotecan—Pruritus—Thiotepa—sarcoma	5.2e-05	0.00136	CcSEcCtD
Topotecan—Gastrointestinal pain—Mitoxantrone—sarcoma	5.19e-05	0.00136	CcSEcCtD
Topotecan—Thrombocytopenia—Etoposide—sarcoma	5.17e-05	0.00135	CcSEcCtD
Topotecan—Abdominal pain—Vincristine—sarcoma	5.16e-05	0.00135	CcSEcCtD
Topotecan—Body temperature increased—Vincristine—sarcoma	5.16e-05	0.00135	CcSEcCtD
Topotecan—Skin disorder—Etoposide—sarcoma	5.13e-05	0.00134	CcSEcCtD
Topotecan—Hyperhidrosis—Etoposide—sarcoma	5.11e-05	0.00133	CcSEcCtD
Topotecan—Urticaria—Mitoxantrone—sarcoma	5.05e-05	0.00132	CcSEcCtD
Topotecan—Anorexia—Etoposide—sarcoma	5.04e-05	0.00132	CcSEcCtD
Topotecan—Diarrhoea—Thiotepa—sarcoma	5.03e-05	0.00132	CcSEcCtD
Topotecan—Abdominal pain—Mitoxantrone—sarcoma	5.02e-05	0.00131	CcSEcCtD
Topotecan—Body temperature increased—Mitoxantrone—sarcoma	5.02e-05	0.00131	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—sarcoma	5.02e-05	0.00131	CcSEcCtD
Topotecan—Diarrhoea—Dactinomycin—sarcoma	4.99e-05	0.00131	CcSEcCtD
Topotecan—Pancytopenia—Epirubicin—sarcoma	4.95e-05	0.00129	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—sarcoma	4.92e-05	0.00129	CcSEcCtD
Topotecan—Neutropenia—Epirubicin—sarcoma	4.87e-05	0.00127	CcSEcCtD
Topotecan—Dizziness—Thiotepa—sarcoma	4.86e-05	0.00127	CcSEcCtD
Topotecan—Hypersensitivity—Vincristine—sarcoma	4.81e-05	0.00126	CcSEcCtD
Topotecan—Paraesthesia—Etoposide—sarcoma	4.74e-05	0.00124	CcSEcCtD
Topotecan—Weight increased—Epirubicin—sarcoma	4.74e-05	0.00124	CcSEcCtD
Topotecan—Dyspnoea—Etoposide—sarcoma	4.71e-05	0.00123	CcSEcCtD
Topotecan—Hypersensitivity—Mitoxantrone—sarcoma	4.68e-05	0.00122	CcSEcCtD
Topotecan—Asthenia—Vincristine—sarcoma	4.68e-05	0.00122	CcSEcCtD
Topotecan—Vomiting—Thiotepa—sarcoma	4.68e-05	0.00122	CcSEcCtD
Topotecan—Pneumonia—Epirubicin—sarcoma	4.67e-05	0.00122	CcSEcCtD
Topotecan—Infestation—Epirubicin—sarcoma	4.64e-05	0.00121	CcSEcCtD
Topotecan—Infestation NOS—Epirubicin—sarcoma	4.64e-05	0.00121	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—sarcoma	4.64e-05	0.00121	CcSEcCtD
Topotecan—Rash—Thiotepa—sarcoma	4.64e-05	0.00121	CcSEcCtD
Topotecan—Dermatitis—Thiotepa—sarcoma	4.63e-05	0.00121	CcSEcCtD
Topotecan—Headache—Thiotepa—sarcoma	4.61e-05	0.0012	CcSEcCtD
Topotecan—Rash—Dactinomycin—sarcoma	4.6e-05	0.0012	CcSEcCtD
Topotecan—Decreased appetite—Etoposide—sarcoma	4.59e-05	0.0012	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—sarcoma	4.58e-05	0.0012	CcSEcCtD
Topotecan—Gastrointestinal disorder—Etoposide—sarcoma	4.56e-05	0.00119	CcSEcCtD
Topotecan—Asthenia—Mitoxantrone—sarcoma	4.56e-05	0.00119	CcSEcCtD
Topotecan—Fatigue—Etoposide—sarcoma	4.55e-05	0.00119	CcSEcCtD
Topotecan—Neuropathy peripheral—Epirubicin—sarcoma	4.55e-05	0.00119	CcSEcCtD
Topotecan—Stomatitis—Epirubicin—sarcoma	4.53e-05	0.00118	CcSEcCtD
Topotecan—Pain—Etoposide—sarcoma	4.52e-05	0.00118	CcSEcCtD
Topotecan—Constipation—Etoposide—sarcoma	4.52e-05	0.00118	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—sarcoma	4.51e-05	0.00118	CcSEcCtD
Topotecan—Diarrhoea—Vincristine—sarcoma	4.46e-05	0.00117	CcSEcCtD
Topotecan—Sweating—Epirubicin—sarcoma	4.45e-05	0.00116	CcSEcCtD
Topotecan—ABCG2—lymph node—sarcoma	4.45e-05	0.00918	CbGeAlD
Topotecan—Hepatobiliary disease—Epirubicin—sarcoma	4.39e-05	0.00115	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—sarcoma	4.39e-05	0.00115	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—sarcoma	4.38e-05	0.00114	CcSEcCtD
Topotecan—Nausea—Thiotepa—sarcoma	4.37e-05	0.00114	CcSEcCtD
Topotecan—Feeling abnormal—Etoposide—sarcoma	4.35e-05	0.00114	CcSEcCtD
Topotecan—Diarrhoea—Mitoxantrone—sarcoma	4.35e-05	0.00114	CcSEcCtD
Topotecan—Nausea—Dactinomycin—sarcoma	4.34e-05	0.00113	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—sarcoma	4.32e-05	0.00113	CcSEcCtD
Topotecan—Gastrointestinal pain—Etoposide—sarcoma	4.32e-05	0.00113	CcSEcCtD
Topotecan—Dizziness—Vincristine—sarcoma	4.31e-05	0.00113	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—sarcoma	4.3e-05	0.00112	CcSEcCtD
Topotecan—Infestation—Doxorubicin—sarcoma	4.3e-05	0.00112	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—sarcoma	4.21e-05	0.0011	CcSEcCtD
Topotecan—Urticaria—Etoposide—sarcoma	4.2e-05	0.0011	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—sarcoma	4.19e-05	0.00109	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—sarcoma	4.19e-05	0.00109	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—sarcoma	4.18e-05	0.00109	CcSEcCtD
Topotecan—Abdominal pain—Etoposide—sarcoma	4.18e-05	0.00109	CcSEcCtD
Topotecan—Body temperature increased—Etoposide—sarcoma	4.18e-05	0.00109	CcSEcCtD
Topotecan—ABCB1—uterus—sarcoma	4.17e-05	0.00861	CbGeAlD
Topotecan—Haemorrhage—Epirubicin—sarcoma	4.17e-05	0.00109	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—sarcoma	4.15e-05	0.00108	CcSEcCtD
Topotecan—Vomiting—Vincristine—sarcoma	4.15e-05	0.00108	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—sarcoma	4.14e-05	0.00108	CcSEcCtD
Topotecan—Sweating—Doxorubicin—sarcoma	4.12e-05	0.00108	CcSEcCtD
Topotecan—Rash—Vincristine—sarcoma	4.11e-05	0.00107	CcSEcCtD
Topotecan—Dermatitis—Vincristine—sarcoma	4.11e-05	0.00107	CcSEcCtD
Topotecan—Headache—Vincristine—sarcoma	4.09e-05	0.00107	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—sarcoma	4.06e-05	0.00106	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—sarcoma	4.05e-05	0.00106	CcSEcCtD
Topotecan—CYP3A4—liver—sarcoma	4.04e-05	0.00834	CbGeAlD
Topotecan—Vomiting—Mitoxantrone—sarcoma	4.04e-05	0.00106	CcSEcCtD
Topotecan—Rash—Mitoxantrone—sarcoma	4e-05	0.00105	CcSEcCtD
Topotecan—Dermatitis—Mitoxantrone—sarcoma	4e-05	0.00105	CcSEcCtD
Topotecan—Headache—Mitoxantrone—sarcoma	3.98e-05	0.00104	CcSEcCtD
Topotecan—Hypersensitivity—Etoposide—sarcoma	3.89e-05	0.00102	CcSEcCtD
Topotecan—ABCB1—lymphoid tissue—sarcoma	3.89e-05	0.00802	CbGeAlD
Topotecan—Haemoglobin—Doxorubicin—sarcoma	3.88e-05	0.00101	CcSEcCtD
Topotecan—Nausea—Vincristine—sarcoma	3.87e-05	0.00101	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—sarcoma	3.87e-05	0.00101	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—sarcoma	3.86e-05	0.00101	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—sarcoma	3.84e-05	0.001	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—sarcoma	3.83e-05	0.001	CcSEcCtD
Topotecan—Asthenia—Etoposide—sarcoma	3.79e-05	0.000991	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—sarcoma	3.78e-05	0.000988	CcSEcCtD
Topotecan—Nausea—Mitoxantrone—sarcoma	3.77e-05	0.000986	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—sarcoma	3.77e-05	0.000984	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—sarcoma	3.76e-05	0.000982	CcSEcCtD
Topotecan—Chills—Epirubicin—sarcoma	3.74e-05	0.000977	CcSEcCtD
Topotecan—Pruritus—Etoposide—sarcoma	3.74e-05	0.000977	CcSEcCtD
Topotecan—Alopecia—Epirubicin—sarcoma	3.68e-05	0.000963	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—sarcoma	3.63e-05	0.000948	CcSEcCtD
Topotecan—Diarrhoea—Etoposide—sarcoma	3.61e-05	0.000945	CcSEcCtD
Topotecan—ABCB1—bone marrow—sarcoma	3.54e-05	0.00731	CbGeAlD
Topotecan—Back pain—Epirubicin—sarcoma	3.51e-05	0.000917	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—sarcoma	3.5e-05	0.000914	CcSEcCtD
Topotecan—Dizziness—Etoposide—sarcoma	3.49e-05	0.000913	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—sarcoma	3.49e-05	0.000912	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—sarcoma	3.48e-05	0.00091	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—sarcoma	3.48e-05	0.000908	CcSEcCtD
Topotecan—Chills—Doxorubicin—sarcoma	3.46e-05	0.000904	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—sarcoma	3.41e-05	0.000891	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—sarcoma	3.37e-05	0.00088	CcSEcCtD
Topotecan—Vomiting—Etoposide—sarcoma	3.36e-05	0.000878	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—sarcoma	3.36e-05	0.000877	CcSEcCtD
Topotecan—Anaemia—Epirubicin—sarcoma	3.35e-05	0.000876	CcSEcCtD
Topotecan—Rash—Etoposide—sarcoma	3.33e-05	0.000871	CcSEcCtD
Topotecan—Dermatitis—Etoposide—sarcoma	3.33e-05	0.00087	CcSEcCtD
Topotecan—Headache—Etoposide—sarcoma	3.31e-05	0.000865	CcSEcCtD
Topotecan—Malaise—Epirubicin—sarcoma	3.27e-05	0.000855	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—sarcoma	3.25e-05	0.000849	CcSEcCtD
Topotecan—Back pain—Doxorubicin—sarcoma	3.25e-05	0.000849	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—sarcoma	3.23e-05	0.000844	CcSEcCtD
Topotecan—Cough—Epirubicin—sarcoma	3.17e-05	0.000828	CcSEcCtD
Topotecan—Nausea—Etoposide—sarcoma	3.14e-05	0.00082	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—sarcoma	3.12e-05	0.000814	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—sarcoma	3.1e-05	0.000811	CcSEcCtD
Topotecan—Chest pain—Epirubicin—sarcoma	3.09e-05	0.000807	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—sarcoma	3.09e-05	0.000807	CcSEcCtD
Topotecan—Myalgia—Epirubicin—sarcoma	3.09e-05	0.000807	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	3.07e-05	0.000802	CcSEcCtD
Topotecan—Discomfort—Epirubicin—sarcoma	3.05e-05	0.000798	CcSEcCtD
Topotecan—Malaise—Doxorubicin—sarcoma	3.03e-05	0.000791	CcSEcCtD
Topotecan—ABCB1—testis—sarcoma	3.02e-05	0.00624	CbGeAlD
Topotecan—Leukopenia—Doxorubicin—sarcoma	3.01e-05	0.000785	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—sarcoma	2.96e-05	0.000774	CcSEcCtD
Topotecan—Infection—Epirubicin—sarcoma	2.94e-05	0.000769	CcSEcCtD
Topotecan—Cough—Doxorubicin—sarcoma	2.93e-05	0.000766	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—sarcoma	2.9e-05	0.000759	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—sarcoma	2.9e-05	0.000758	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—sarcoma	2.88e-05	0.000752	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—sarcoma	2.86e-05	0.000748	CcSEcCtD
Topotecan—ABCB1—liver—sarcoma	2.86e-05	0.0059	CbGeAlD
Topotecan—Chest pain—Doxorubicin—sarcoma	2.86e-05	0.000747	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—sarcoma	2.86e-05	0.000747	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—sarcoma	2.86e-05	0.000747	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	2.84e-05	0.000742	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—sarcoma	2.82e-05	0.000738	CcSEcCtD
Topotecan—Anorexia—Epirubicin—sarcoma	2.82e-05	0.000738	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—sarcoma	2.74e-05	0.000716	CcSEcCtD
Topotecan—Infection—Doxorubicin—sarcoma	2.72e-05	0.000711	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—sarcoma	2.7e-05	0.000705	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—sarcoma	2.69e-05	0.000702	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—sarcoma	2.68e-05	0.000701	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—sarcoma	2.66e-05	0.000696	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—sarcoma	2.66e-05	0.000695	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—sarcoma	2.65e-05	0.000692	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—sarcoma	2.64e-05	0.00069	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—sarcoma	2.61e-05	0.000683	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—sarcoma	2.61e-05	0.000681	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—sarcoma	2.57e-05	0.000673	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—sarcoma	2.56e-05	0.000668	CcSEcCtD
Topotecan—Fatigue—Epirubicin—sarcoma	2.55e-05	0.000667	CcSEcCtD
Topotecan—Pain—Epirubicin—sarcoma	2.53e-05	0.000662	CcSEcCtD
Topotecan—Constipation—Epirubicin—sarcoma	2.53e-05	0.000662	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—sarcoma	2.5e-05	0.000652	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—sarcoma	2.46e-05	0.000643	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—sarcoma	2.44e-05	0.000638	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—sarcoma	2.44e-05	0.000638	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—sarcoma	2.42e-05	0.000633	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—sarcoma	2.41e-05	0.00063	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—sarcoma	2.38e-05	0.000623	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—sarcoma	2.37e-05	0.000618	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—sarcoma	2.36e-05	0.000617	CcSEcCtD
Topotecan—Urticaria—Epirubicin—sarcoma	2.35e-05	0.000615	CcSEcCtD
Topotecan—Constipation—Doxorubicin—sarcoma	2.34e-05	0.000612	CcSEcCtD
Topotecan—Pain—Doxorubicin—sarcoma	2.34e-05	0.000612	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—sarcoma	2.34e-05	0.000612	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—sarcoma	2.34e-05	0.000612	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—sarcoma	2.26e-05	0.00059	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—sarcoma	2.24e-05	0.000586	CcSEcCtD
Topotecan—ABCB1—lymph node—sarcoma	2.19e-05	0.00453	CbGeAlD
Topotecan—Hypersensitivity—Epirubicin—sarcoma	2.18e-05	0.00057	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—sarcoma	2.18e-05	0.000569	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—sarcoma	2.17e-05	0.000566	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—sarcoma	2.17e-05	0.000566	CcSEcCtD
Topotecan—Asthenia—Epirubicin—sarcoma	2.12e-05	0.000555	CcSEcCtD
Topotecan—Pruritus—Epirubicin—sarcoma	2.1e-05	0.000548	CcSEcCtD
Topotecan—Diarrhoea—Epirubicin—sarcoma	2.03e-05	0.00053	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—sarcoma	2.02e-05	0.000528	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—sarcoma	1.97e-05	0.000514	CcSEcCtD
Topotecan—Dizziness—Epirubicin—sarcoma	1.96e-05	0.000512	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—sarcoma	1.94e-05	0.000507	CcSEcCtD
Topotecan—Vomiting—Epirubicin—sarcoma	1.88e-05	0.000492	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—sarcoma	1.87e-05	0.00049	CcSEcCtD
Topotecan—Rash—Epirubicin—sarcoma	1.87e-05	0.000488	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—sarcoma	1.87e-05	0.000488	CcSEcCtD
Topotecan—Headache—Epirubicin—sarcoma	1.86e-05	0.000485	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—sarcoma	1.81e-05	0.000474	CcSEcCtD
Topotecan—Nausea—Epirubicin—sarcoma	1.76e-05	0.00046	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—sarcoma	1.74e-05	0.000455	CcSEcCtD
Topotecan—Rash—Doxorubicin—sarcoma	1.73e-05	0.000452	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—sarcoma	1.73e-05	0.000451	CcSEcCtD
Topotecan—Headache—Doxorubicin—sarcoma	1.72e-05	0.000449	CcSEcCtD
Topotecan—Nausea—Doxorubicin—sarcoma	1.63e-05	0.000425	CcSEcCtD
